Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Torrent Pharmaceuticals Ltd (TORNTPHARM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10133
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrology, cancer, gynecology and pediatric segments. Torrent has a fully equipped research center that is approved by the US FDA and various other regulatory authorities and manufacturing facilities at Indrad, Baddi, Sikkim, Dahej and Pithampur. The company has presence in more than forty countries worldwide and has wholly owned subsidiaries in USA, the UK, Germany, Russia, Brazil, Mexico, Philippines and other major markets. Torrent is headquartered in Ahmedabad, Gujarat, India.

Torrent Pharmaceuticals Ltd (TORNTPHARM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Torrent Pharma Acquires Branded Business from Unichem Labs for USD556.6 Million 13
Torrent Pharma Acquires Two Brands of Women Healthcare Segment from Novartis 15
Torrent Pharma Acquires Active Pharmaceutical Ingredients Manufacturing Unit in Vizag from Glochem Industries 16
Torrent Pharma to Acquire Minocycline Tablet From Ranbaxy Labs 17
Torrent Pharma Completes Acquisition Of Formulations Business Of Elder Pharma For US$333 Million 18
Private Equity 20
ChrysCapital Acquires 3% Stake In Torrent Pharma For US$40 Million 20
Partnerships 21
Navamedic Enters Into Distribution Agreement With Torrent Pharma 21
Licensing Agreements 22
Torrent Pharma Enters into Licensing Agreement with Reliance Life Sciences 22
Equity Offering 23
Torrent Pharma May Raise USD231 Million in Private Placement of Share 23
Torrent Pharma Plans to Raise up to USD782 Million in Private Placement of Securities 24
Vista Pharma to Raise Funds through Public Offering of Shares and Warrants 25
Torrent Pharma Plans Private Placement of Shares for USD488.2 Million 26
Debt Offering 27
Torrent Pharma Plans to Raise up to USD1.95 Billion in Private Placement of Debt Securities 27
Torrent Pharma Raises USD155 Million in Private Placement of 7.98% Debentures Due 2025 28
Torrent Pharma Plans Private Placement of Bonds for USD1.22 Billion 29
Acquisition 30
Torrent Pharma Acquires Bio-Pharm 30
ChrysCapital Divests Stake in Torrent Pharma 31
Torrent Pharma Acquires Zyg Pharma 32
Torrent Pharma Plans To Acquire Pharma Companies 33
Torrent Pharmaceuticals Ltd – Key Competitors 34
Torrent Pharmaceuticals Ltd – Key Employees 35
Torrent Pharmaceuticals Ltd – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 39
Financial Announcements 39
Nov 03, 2018: Torrent Pharma Q2 net drags 12% to Rs 1.7 bn on rupee decline, US recall 39
Jul 31, 2017: Torrent Pharma announces Q1 FY 2017-18 Results 40
May 26, 2017: Torrent Pharmaceuticals Reports Revenue Of INR19.8 Billion In Fiscal 2017 42
Corporate Communications 43
Aug 31, 2018: Torrent Pharmaceuticals: Intimation of change in Chief Financial Officer 43
Jul 26, 2018: Torrent Pharmaceuticals: Intimation of cessation of director of the company 44
Jul 22, 2017: Torrent Pharmaceuticals : Intimation of Resignation of Director of the Company 45
Product News 46
Aug 23, 2018: Torrent Pharmaceuticals limited issues voluntary nationwide recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Torrent Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Torrent Pharma Acquires Branded Business from Unichem Labs for USD556.6 Million 13
Torrent Pharma Acquires Two Brands of Women Healthcare Segment from Novartis 15
Torrent Pharma Acquires Active Pharmaceutical Ingredients Manufacturing Unit in Vizag from Glochem Industries 16
Torrent Pharma to Acquire Minocycline Tablet From Ranbaxy Labs 17
Torrent Pharma Completes Acquisition Of Formulations Business Of Elder Pharma For US$333 Million 18
ChrysCapital Acquires 3% Stake In Torrent Pharma For US$40 Million 20
Navamedic Enters Into Distribution Agreement With Torrent Pharma 21
Torrent Pharma Enters into Licensing Agreement with Reliance Life Sciences 22
Torrent Pharma May Raise USD231 Million in Private Placement of Share 23
Torrent Pharma Plans to Raise up to USD782 Million in Private Placement of Securities 24
Vista Pharma to Raise Funds through Public Offering of Shares and Warrants 25
Torrent Pharma Plans Private Placement of Shares for USD488.2 Million 26
Torrent Pharma Plans to Raise up to USD1.95 Billion in Private Placement of Debt Securities 27
Torrent Pharma Raises USD155 Million in Private Placement of 7.98% Debentures Due 2025 28
Torrent Pharma Plans Private Placement of Bonds for USD1.22 Billion 29
Torrent Pharma Acquires Bio-Pharm 30
ChrysCapital Divests Stake in Torrent Pharma 31
Torrent Pharma Acquires Zyg Pharma 32
Torrent Pharma Plans To Acquire Pharma Companies 33
Torrent Pharmaceuticals Ltd, Key Competitors 34
Torrent Pharmaceuticals Ltd, Key Employees 35
Torrent Pharmaceuticals Ltd, Other Locations 36
Torrent Pharmaceuticals Ltd, Subsidiaries 36

List of Figures
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • State Bank of India:企業のM&A・事業提携・投資動向
    State Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's State Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • GEDI Gruppo Editoriale SpA (GEDI):企業の財務・戦略的SWOT分析
    GEDI Gruppo Editoriale SpA (GEDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Desitin Arzneimittel GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Desitin Arzneimittel GmbH (Desitin), formerly Desitin Compagnie mbH is a healthcare products provider that offers therapeutic products. The company develops and markets products for the treatment of neurological and psychiatric illnesses. It provides products for various therapeutic areas su …
  • Grupa Lotos SA (LTS):石油・ガス:M&Aディール及び事業提携情報
    Summary Grupa Lotos S.A. (Grupa Lotos) is an integrated energy company. The company carries out various activities such as the extraction and refining of crude oil; processing of petroleum into finished products; and the wholesale and retail distribution and sale of petroleum products. Its product p …
  • NextPharma Technologies Holding Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NextPharma Technologies Holding Ltd (NextPharma) is a contract development and manufacturing organization that provides pharmaceutical products and services. The company offers wide range of services such as pharmaceutical development, analytical services, clinical trials services, commercia …
  • RSWM Ltd. (RSWM):企業の財務・戦略的SWOT分析
    RSWM Ltd. (RSWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CryoLife Inc (CRY)-医療機器分野:企業M&A・提携分析
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio encompasses preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide …
  • Forrester Research, Inc.
    Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AB Science SA (AB):企業の財務・戦略的SWOT分析
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • ATCO Power Ltd:企業の戦略的SWOT分析
    ATCO Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company. The company develops cellular therapies for the treatment cardiovascular indications and autoimmune diseases. The company's products pipeline includes CLBS03 is an autologous ex vivo p …
  • Lantern Pharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Lantern Pharma Inc (Lantern Pharma) is a drug development company that discovers and develops therapies for various cancer types. The company’s pipeline products include Irofulven-1, an anti-tumor agent is developed to fight against multi-drug resistant cancers. Its Irofulven-1 is used for t …
  • Harte Hanks Inc (HHS):企業の財務・戦略的SWOT分析
    Harte Hanks Inc (HHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • China Ming Yang Wind Power Group Ltd-エネルギー分野:企業M&A・提携分析
    Summary China Ming Yang Wind Power Group Limited (Ming Yang) is a wind equipment company that designs, manufactures, sells and services wind turbines. It also provides services such as technical training, transportation of wind turbines, installation of wind turbines, debugging service of wind gener …
  • Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstre …
  • Fnm Spa
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • SBA Communications Corp (SBAC):企業の財務・戦略的SWOT分析
    Summary SBA Communications Corp (SBA) operates as a wireless communication infrastructure company . The company offers site leasing and site development services. It provides infrastructure solution such as towers, distributed antenna systems (DAS), buildings, rooftops and small cells. The company p …
  • Extendicare Inc.
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Triple-S Management Corp (GTS):企業の財務・戦略的SWOT分析
    Triple-S Management Corp (GTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆